Search results
FDA approves self-collection screening for virus that causes cervical cancer - The Boston Globe
The Boston Globe· 2 hours ago“It provides women who might not have otherwise had the opportunity — or inclination — to get...
Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress By Investing.com
Investing.com· 2 hours agoThe company reported positive efficacy data comparing ibezapolstat favorably with the current...
FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
Benzinga via Yahoo Finance· 6 hours agoTuesday, Ascendis Pharma A/S (NASDAQ:ASND) announced that the FDA extended the review date for...
FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
Zacks via Yahoo Finance· 9 hours agoPer the FDA, the data submitted by Ascendis (ASND) for its hormone replacement therapy constitutes a...
FDA greenlights self-collection of vaginal samples for cervical cancer screening
KEYT 3 Santa Barbara· 2 hours agoTwo health care businesses – biotechnology company Roche and medical technology firm Becton, Dickson...
Throw out COVID-19 tests made by Cue Health, FDA warns
WJZY via Yahoo News· 2 hours agoCue Health, headquartered in San Diego, received emergency use FDA authorization for two COVID-19...
Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
Zacks via Yahoo Finance· 1 day agoPhilips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power...
FDA approves HPV self-test kit
UPI· 8 hours agoEach year, about 11,500 U.S. women are diagnosed with cervical cancer and about 4,000 women die from it, according to the U.S. Centers for Disease...
FDA issues recall notice for Philips after another respiratory device fails
Medical Device Network via Yahoo Finance· 13 hours agoThe FDA has issued the notice for the company’s Trilogy EVO Continuous Ventilators, warning that...
Earnings call: Lumos Pharma gears up for Phase 3 trial of LUM-201 By Investing.com
Investing.com· 2 hours agoThe company has completed a constructive End-of-Phase 2 Meeting with the FDA and is planning to...
